Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.
D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D001706:Biopsy; D017252:CD3 Complex / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D016022:Case-Control Studies; D015331:Cohort Studies; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology; D006526:Hepatitis C / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000473:pathology / Q000821:virology; D008103:Liver Cirrhosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D054353:Perforin / Q000378:metabolism; D011379:Prognosis; D012367:RNA, Viral / Q000097:blood*; D014779:Virus Replication
D017252:CD3 Complex; D018937:Hepatitis C Antibodies; D012367:RNA, Viral; D054353:Perforin; D000410:Alanine Transaminase